ClinicalTrials.gov
ClinicalTrials.gov Menu

EMDR in the Treatment of Specific Phobia.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00184145
Recruitment Status : Withdrawn (approval of ethical committee was denied)
First Posted : September 16, 2005
Last Update Posted : February 28, 2017
Sponsor:
Collaborator:
St. Olavs Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
The purpose for this study is to determine whether EMDR is effective in the treatment of specific (animal) phobia.

Condition or disease Intervention/treatment Phase
Specific Phobia Other: EMDR (Eye Movement Desensitization and Reprocessing) Other: Exposure therapy Not Applicable

Detailed Description:
Aims: To test the hypothesis that one session EMDR is more effective for the treatment of specific (animal) phobia than relaxation immediately after treatment and at follow-up. Secondly to test whether an additional one-session exposure therapy offered to both treatment groups (EMDR patients and relaxation patients) improves outcome in the EMDR-group and results in equal outcome for both treatment groups.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: EMDR (Eye Movement Desensitization and Reprocessing) in the Treatment of Specific Phobia. A Randomised Controlled Trial.
Actual Study Start Date : June 2004
Actual Primary Completion Date : September 2004
Actual Study Completion Date : September 2004

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Phobias
U.S. FDA Resources

Arm Intervention/treatment
Experimental: EMDR
The experimental group was treated for animal phobia by EMDR, control group received an attention placebo (relaxation plus breathing exercises). Afterwards, both groups were treated by exposure therapy (therapy of choice for animal phobia).
Other: EMDR (Eye Movement Desensitization and Reprocessing)
Psychotherapy which is approved for PTSD.
Other: Exposure therapy
All participants in the study received exposure therapy som second treatment. Exposure therapy is the therapy of choice for animal phobia.



Primary Outcome Measures :
  1. Behavioral Approach Test towards the feared animal. [ Time Frame: Before and after each treatment ]

Secondary Outcome Measures :
  1. Scores on self-report questionnaires on phobic symptoms [ Time Frame: Before and after both treatments ]
  2. Neuropsychological function [ Time Frame: Before first treatment, some measures also before second treatment ]
  3. Cognitive strategies [ Time Frame: Before both treatments ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with Specific (Animal) Phobia

Exclusion Criteria:

  • Current or past psychotic disorder
  • Current substance dependence or abuse
  • Serious physical illness
  • Active suicidal behavior
  • Bipolar affective disorder
  • Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00184145


Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Investigators
Principal Investigator: Ludger Kaiser, Doctor

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184145     History of Changes
Other Study ID Numbers: EPLK-2004
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: February 28, 2017
Last Verified: February 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Norwegian University of Science and Technology:
Specific (Animal) Phobia
EMDR
Exposure therapy

Additional relevant MeSH terms:
Phobic Disorders
Anxiety Disorders
Mental Disorders